Results 101 to 110 of about 38,461 (234)

Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

open access: yesObesity, Volume 34, Issue 6, Page 1210-1229, June 2026.
ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim   +3 more
wiley   +1 more source

GRKs and arrestins: Nomenclature and functions in GPCR‐dependent and ‐independent signalling

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 11, Page 2619-2633, June 2026.
G protein‐coupled receptor (GPCR) kinases (GRKs) and arrestins play a critical role in the regulation of GPCR signalling. Historic names of mammalian GRKs were replaced by systematic ones in the 1990s; however, both kinds of names are currently in use for mammalian arrestins.
Vsevolod V. Gurevich
wiley   +1 more source

Unexplained Elevated Vitamin B12: Consider Macro‐B12

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 3, Page 646-651, June 2026.
ABSTRACT Introduction Elevated vitamin B12 concentration can be caused by supplementation, liver disease, kidney disease, or myeloid malignancies. Persistent, unexplained elevations of vitamin B12 can raise concern among patients and may lead to invasive diagnostic procedures, including bone marrow biopsy.
Evelien G. E. Hurkmans   +3 more
wiley   +1 more source

Genotype–Phenotype Spectrum of Non‐Syndromic Monogenic Obesity in a National Paediatric Cohort

open access: yesPediatric Obesity, Volume 21, Issue 6, June 2026.
ABSTRACT Objective Non‐syndromic monogenic obesity, caused by defects in the leptin‐melanocortin pathway, presents with early‐onset severe obesity and hyperphagia, but genotype–phenotype and metabolic correlations across different genetic forms remain unclear.
Ahmet Kahveci   +28 more
wiley   +1 more source

Validation of Immunoassays for Total Thyroxine and Free Thyroxine and Age and Sex‐Related Variation in Thyroid Hormone Serum Concentrations in Orangutans (Pongo sp.)

open access: yesJournal of Medical Primatology, Volume 55, Issue 3, June 2026.
ABSTRACT Background Thyroid disease is reported in orangutans, but to properly diagnose and manage these disorders, reference intervals for circulating thyroid hormones are needed. Methods Commercial immunoassay kits for total thyroxine (TT4) and free thyroxine (FT4) were validated for use in orangutans (Pongo spp.).
Melissa A. Fayette   +4 more
wiley   +1 more source

Influence of the gut microbiome on appetite-regulating neuropeptides in the hypothalamus: Insight from conventional, antibiotic-treated, and germ-free mouse models of anorexia nervosa

open access: yesNeurobiology of Disease
Recent research highlights the profound impact of the gut microbiome on neuropsychiatric disorders, shedding light on its potential role in shaping human behavior.
Radka Roubalová   +6 more
doaj   +1 more source

Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone

open access: yes, 1981
Neurotensin (NT), administered intracisternally to mice, produced significant dose-dependent antinociception in three analgesic tests: tail immersion, hot-plate and acetic acid writhing. Naloxone (1-5 mg/kg), an opiate antagonist administered i.p. 20 min
Nemeroff, C B   +4 more
core  

Update of the risk assessment on dioxins and dioxin‐like PCBs in feed and food

open access: yesEFSA Journal, Volume 24, Issue 6, June 2026.
Abstract The European Commission asked EFSA to update its 2018 risk assessment on polychlorinated dibenzo‐p‐dioxins and dibenzofurans (PCDD/Fs) and dioxin‐like polychlorinated biphenyls (DL‐PCBs) in feed and food, based on the 2022 WHO Toxic Equivalency Factors (WHO2022‐TEFs).
EFSA Panel on Contaminants in the Food Chain (CONTAM Panel)   +27 more
wiley   +1 more source

Activity and specificity of synthetic thyrotropin-releasing hormone in man

open access: yes, 1970
The serum levels of thyrotropin (TSH) increased two minutes after a quick single iv. injection of 800 μg of synthetic thyrotropin releasing hormone (TRH) into a normal male subject. The peak elevation of TSH occurred after 30 minutes, and was 370% higher
Bowers, C.Y   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy